Securing Gene Synthesis Act

The Securing Gene Synthesis Act requires gene synthesis providers (companies making custom DNA/RNA) and manufacturers of gene synthesis equipment to implement screening protocols to detect potential misuse of their products. It mandates verification of compliance with these protocols and ties federal funding to adherence, allowing agencies to withhold funds from non-compliant entities. The bill defines key terms like "gene synthesis product" (excluding basic chemicals or sequencing byproducts) and sets a 2026 deadline for federal agencies to report compliance policies. This directly affects companies producing synthetic genetic material for research or commercial use, imposing new regulatory obligations to mitigate misuse risks.